Reassessment of the Role of Methane Production between Irritable Bowel Syndrome and Functional Constipation

被引:1
|
作者
Furnari, Manuele [1 ]
Savarino, Edoardo [1 ]
Bruzzone, Luca [1 ]
Moscatelli, Alessandro [1 ]
Gemignani, Lorenzo [1 ]
Gianini, Edoardo G. [1 ]
Zentilin, Patrizia [1 ]
Dulbecco, Pietro [1 ]
Savarino, Vincenzo [1 ]
机构
[1] Univ Genoa, Gastroenterol Unit, Dept Internal Med, I-16132 Genoa, Italy
关键词
Methane; breath test; constipation; functional gastrointestinal disorders; INTESTINAL BACTERIAL OVERGROWTH; SULFATE-REDUCING BACTERIA; GASTROINTESTINAL-DISEASES; CLINICAL EFFECTIVENESS; METHANOGENIC BACTERIA; DIVERTICULAR-DISEASE; LACTOSE-INTOLERANCE; BREATH TEST; RIFAXIMIN; EXCRETION;
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background & Aims: Modifications of intestinal gas due to changes in microbiota may produce different symptoms. Our aim was to assess whether different patterns of hydrogen (H-2) and methane (CH4) excretion were related to some intestinal disturbances. Methods. Six hundred and twenty-nine consecutive patients underwent a 50g-glucose breath test (GBT) on account of intestinal symptoms, which were evaluated by means of a questionnaire. "H-2-producers" and "CH4-producers" were defined as with the presence of H-2 peak >12ppm more than the basal sample and mean CH4 excretion of 2ppm, respectively. Forty healthy subjects were studied as controls. Results. A small intestinal bacterial overgrowth was found in 45 cases (7.2%) and was associated with older age (p=0.0122). Methane production occurred in 32.3% of the study population. Methane excretion was strictly related to chronic constipation (p<0.001). Median CH4 excretion was higher in constipated patients compared with patients with normal daily stools (p=0.0406) and even more with patients complaining of diarrhea (p=0.0011). Different criteria for defining "methane-producers" provided similar results. Mean methane excretion of "methane producers" was 30.3ppm in functional constipation and 21.5ppm in constipation-irritable bowel syndrome (C-IBS) (p=0.0458). Conclusions. Methane excretion is clearly associated with alterations in intestinal motility, particularly favouring those with constipation. Mean methane excretion was higher in subjects suffering from functional constipation than C-IBS. Mean methane excretion >= 2ppm appears to be an appropriate term to define "methane-producers".
引用
收藏
页码:157 / 163
页数:7
相关论文
共 50 条
  • [41] Rifaximin for Irritable Bowel Syndrome without Constipation
    Khazeni, Nayer
    Perlroth, Daniella
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (15): : 1467 - 1468
  • [42] Focus on Pharmacotherapy for Irritable Bowel Syndrome with Constipation
    Liu, Joy J.
    Brenner, Darren M.
    GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2021, 50 (03) : 639 - 653
  • [44] Tegaserod in the treatment of irritable bowel syndrome with constipation
    Saad, Richard
    Chey, William D.
    WOMENS HEALTH, 2006, 2 (01) : 29 - 42
  • [45] Editorial: minesapride for irritable bowel syndrome with constipation
    Black, Christopher J.
    Barberio, Brigida
    Ford, Alexander C.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 52 (04) : 713 - 714
  • [46] Lubiprostone (Amitiza) for irritable bowel syndrome with constipation
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2008, 50 (1290): : 53 - 54
  • [47] Anorectal biofeedback therapy improves bloating in irritable bowel syndrome and functional constipation
    Malcolm, A.
    Hansen, R. D.
    Suttor, V. P.
    Prott, G. M.
    Simmons, L.
    Kellow, J. E.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2008, 23 : A293 - A293
  • [48] A RETROSPECTIVE REVIEW OF LINACLOTIDE TREATMENT FOR CHILDREN WITH FUNCTIONAL CONSTIPATION OR IRRITABLE BOWEL SYNDROME
    Baaleman, Desiree F.
    Gupta, Shivani
    Benninga, Marc A.
    Bali, Neetu
    Vaz, Karla
    Yacob, Desale
    Di Lorenzo, Carlo
    Lu, Peter L.
    GASTROENTEROLOGY, 2020, 158 (06) : S356 - S356
  • [49] Dried plums, constipation and the irritable bowel syndrome
    Halmos, E. P.
    Gibson, P. R.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2011, 34 (03) : 396 - 397
  • [50] Tenapanor (Ibsrela) for Irritable Bowel Syndrome with Constipation
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2022, 64 (1652): : 91 - 94